lysergic acid diethylamide has been researched along with Hematologic Neoplasms in 1 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Hematologic Neoplasms: Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnett, BS | 1 |
| Ziegler, K | 1 |
| Doblin, R | 1 |
| Carlo, AD | 1 |
1 other study available for lysergic acid diethylamide and Hematologic Neoplasms
| Article | Year |
|---|---|
Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.
Topics: Adult; Hallucinogens; Hematologic Neoplasms; Humans; Lysergic Acid Diethylamide; Neoplasms; Phenethy | 2022 |